Evidence map›Paper›PMID 41923890›Full record

ArticleOpen forum infectious diseases2026

Daniel N Willis, Erik R Dubberke, Robert J Hayashi, Phillip I Tarr, David B Haslam, Tiffany Hink, Jingqin Luo, Yu Tao, Amruta Padhye, Erin M Hall and 1 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Secondary Oral Vancomycin Prophylaxis andOpen forum infectious diseases · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel N WillisDepartment of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.ORCID https://orcid.org/0000-0002-7011-4586
Erik R DubberkeDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
Robert J HayashiDepartment of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.
Phillip I TarrDepartment of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.
David B HaslamDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Tiffany HinkDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
Jingqin LuoDepartment of Surgery, Washington University School of Medicine, St Louis, Missouri, USA.ORCID https://orcid.org/0000-0003-2759-3072
Yu TaoDepartment of Surgery, Washington University School of Medicine, St Louis, Missouri, USA.
Amruta PadhyeDepartment of Pediatrics, School of Medicine, University of Missouri, Columbia, Missouri, USA.ORCID https://orcid.org/0000-0002-1524-5612
Erin M HallDepartment of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Gregory A StorchDepartment of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pediatric oncology and hematopoietic stem cell transplant (HSCT) patients have elevated risk for Methods: We retrospectively studied 276 stools longitudinally collected over 34 months from 32 HSCT and 12 oncology patients treated at a single tertiary center. Specimens were cultured for Results: Baseline cultures were positive in 16 (50%) HSCT patients and 2 (12%) oncology. On subsequent samples, 64% of patients who were initially negative acquired colonization: 8 of 15 (53%) HSCT and 8 of 10 (80%) oncology. Nine clonal strains and 25 multilocus sequence types were identified by whole genome sequencing, with 4 clones found in both cohorts. Nine patients had different strains at different time points. Seven clonal strains were found in multiple patients. Seven (15.9%) patients had symptomatic CDI. Conclusions:

Identifiers

PMID41923890
PMCPMC13037757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.